| 6EV | Name: | 5-methylidene-3-(methylsulfanyl)-2-benzothiophen-4(5H)-one | Formula: | C10 H8 O S2 | SMILES: | C=C2/C=Cc1csc(SC)c1C2=O | InChi: | InChI=1S/C10H8OS2/c1-6-3-4-7-5-13-10(12-2)8(7)9(6)11/h3-5H,1H2,2H3 | Definition date: | 2016-03-23 | Last modified: | 2016-11-25 | Release date: | 2016-11-30 | Identifier: | 5-methylidene-3-(methylsulfanyl)-2-benzothiophen-4(5H)-one |
|
| 63K | Name: | 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-[2-(morpholin-4-yl)ethyl]urea | Formula: | C25 H23 F N8 O2 S2 | SMILES: | c1cc(ccc1c3ccc2nnc(n2n3)Sc5ccc6nc(NC(NCCN4CCOCC4)=O)sc6c5)F | InChi: | InChI=1S/C25H23FN8O2S2/c26-17-3-1-16(2-4-17)19-7-8-22-30-31-25(34(22)32-19)37-18-5-6-20-21(15-18)38-24(28-20)29-23(35)27-9-10-33-11-13-36-14-12-33/h1-8,15H,9-14H2,(H2,27,28,29,35) | Definition date: | 2016-01-20 | Last modified: | 2016-11-18 | Release date: | 2016-11-23 | Identifier: | 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-[2-(morpholin-4-yl)ethyl]urea |
|
| TD5 | Name: | (4~{R})-4-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl(phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3-ium-2-yl]-4-oxidanyl-butanoic acid | Formula: | C16 H25 N4 O10 P2 S | SMILES: | Cc1ncc(C[n+]2c(C)c(CCO[P](O)(=O)O[P](O)(O)=O)sc2[CH](O)CCC(O)=O)c(N)n1 | InChi: | InChI=1S/C16H24N4O10P2S/c1-9-13(5-6-29-32(27,28)30-31(24,25)26)33-16(12(21)3-4-14(22)23)20(9)8-11-7-18-10(2)19-15(11)17/h7,12,21H,3-6,8H2,1-2H3,(H5-,17,18,19,22,23,24,25,26,27,28)/p+1/t12-/m1/s1 | Definition date: | 2015-11-20 | Last modified: | 2016-10-28 | Release date: | 2016-11-02 | Identifier: | (4~{R})-4-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl(phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3-ium-2-yl]-4-oxidanyl-butanoic acid |
|
| 5AU | Name: | Di-glutathione-PhenylArsine | Formula: | C26 H37 As N6 O12 S2 | SMILES: | NC(CCC(NC(CS[As](SCC(NC(=O)CCC(C(O)=O)N)C(=O)NCC(O)=O)c1ccccc1)C(NCC(O)=O)=O)=O)C(O)=O | InChi: | InChI=1S/C26H37AsN6O12S2/c28-15(25(42)43)6-8-19(34)32-17(23(40)30-10-21(36)37)12-46-27(14-4-2-1-3-5-14)47-13-18(24(41)31-11-22(38)39)33-20(35)9-7-16(29)26(44)45/h1-5,15-18H,6-13,28-29H2,(H,30,40)(H,31,41)(H,32,34)(H,33,35)(H,36,37)(H,38,39)(H,42,43)(H,44,45)/t15-,16-,17-,18-/m0/s1 | Definition date: | 2015-08-31 | Last modified: | 2016-10-21 | Release date: | 2016-10-26 | Identifier: | (2S,7R,13R,18S)-2,18-diamino-7,13-bis[(carboxymethyl)carbamoyl]-5,15-dioxo-10-phenyl-9,11-dithia-6,14-diaza-10-arsanonadecane-1,19-dioic acid (non-preferred name) |
|
| 6B8 | Name: | (2S,3R,4R)-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-4-(methylsulfanyl)-3,4-dihydro-2H-pyrrole-5-carboxylic acid | Formula: | C11 H17 N O4 S | SMILES: | OC(C=1C(C(C(C(C(O)C)C=O)N=1)C)SC)=O | InChi: | InChI=1S/C11H17NO4S/c1-5-8(7(4-13)6(2)14)12-9(11(15)16)10(5)17-3/h4-8,10,14H,1-3H3,(H,15,16)/t5-,6-,7-,8-,10-/m1/s1 | Definition date: | 2016-03-01 | Last modified: | 2016-10-07 | Release date: | 2016-10-12 | Identifier: | (2S,3R,4R)-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-4-(methylsulfanyl)-3,4-dihydro-2H-pyrrole-5-carboxylic acid |
|
| 6M6 | Name: | S-[(2-phenylethyl)carbamothioyl]-L-cysteine | Formula: | C12 H16 N2 O2 S2 | SMILES: | S(C(NCCc1ccccc1)=S)CC(C(O)=O)N | InChi: | InChI=1S/C12H16N2O2S2/c13-10(11(15)16)8-18-12(17)14-7-6-9-4-2-1-3-5-9/h1-5,10H,6-8,13H2,(H,14,17)(H,15,16)/t10-/m0/s1 | Definition date: | 2016-05-05 | Last modified: | 2016-10-07 | Release date: | 2016-10-12 | Identifier: | S-[(2-phenylethyl)carbamothioyl]-L-cysteine |
|
| GVX | Name: | L-gamma-glutamyl-S-[(2-phenylethyl)carbamothioyl]-L-cysteinylglycine | Formula: | C19 H26 N4 O6 S2 | SMILES: | OC(C(CCC(=O)NC(C(=O)NCC(O)=O)CSC(=S)NCCc1ccccc1)N)=O | InChi: | InChI=1S/C19H26N4O6S2/c20-13(18(28)29)6-7-15(24)23-14(17(27)22-10-16(25)26)11-31-19(30)21-9-8-12-4-2-1-3-5-12/h1-5,13-14H,6-11,20H2,(H,21,30)(H,22,27)(H,23,24)(H,25,26)(H,28,29)/t13-,14-/m0/s1 | Definition date: | 2016-05-05 | Last modified: | 2016-10-07 | Release date: | 2016-10-12 | Identifier: | L-gamma-glutamyl-S-[(2-phenylethyl)carbamothioyl]-L-cysteinylglycine |
|
| 72O | Name: | 2-[(3-chloranylphenoxy)methyl]-4-methyl-5-(1~{H}-pyrazol-5-yl)-1,3-thiazole | Formula: | C14 H12 Cl N3 O S | SMILES: | Cc1nc(COc2cccc(Cl)c2)sc1c3[nH]ncc3 | InChi: | InChI=1S/C14H12ClN3OS/c1-9-14(12-5-6-16-18-12)20-13(17-9)8-19-11-4-2-3-10(15)7-11/h2-7H,8H2,1H3,(H,16,18) | Definition date: | 2016-08-17 | Last modified: | 2016-09-30 | Release date: | 2016-10-05 | Identifier: | 2-[(3-chloranylphenoxy)methyl]-4-methyl-5-(1~{H}-pyrazol-5-yl)-1,3-thiazole |
|
| 5H6 | Name: | 5-(5-chlorothiophen-2-yl)-1,2-oxazole-3-carboxylic acid | Formula: | C8 H4 Cl N O3 S | SMILES: | c2c(c1cc(C(O)=O)no1)sc(c2)Cl | InChi: | InChI=1S/C8H4ClNO3S/c9-7-2-1-6(14-7)5-3-4(8(11)12)10-13-5/h1-3H,(H,11,12) | Definition date: | 2015-09-24 | Last modified: | 2016-09-30 | Release date: | 2016-10-05 | Identifier: | 5-(5-chlorothiophen-2-yl)-1,2-oxazole-3-carboxylic acid |
|
| TDN | Name: | 2-[(2E)-3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-2-(1-oxidanylpropylidene)-1,3-thiazol-5-yl]ethyl phosphono hydrogen phosphate | Formula: | C15 H24 N4 O8 P2 S | SMILES: | CCC(O)=C1SC(=C(C)N1Cc2cnc(C)nc2N)CCO[P](O)(=O)O[P](O)(O)=O | InChi: | InChI=1S/C15H24N4O8P2S/c1-4-12(20)15-19(8-11-7-17-10(3)18-14(11)16)9(2)13(30-15)5-6-26-29(24,25)27-28(21,22)23/h7,20H,4-6,8H2,1-3H3,(H,24,25)(H2,16,17,18)(H2,21,22,23)/b15-12+ | Definition date: | 2016-04-07 | Last modified: | 2016-09-23 | Release date: | 2016-09-28 | Identifier: | 2-[(2~{E})-3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-2-(1-oxidanylpropylidene)-1,3-thiazol-5-yl]ethyl phosphono hydrogen phosphate |
|
| 5GC | Name: | 5-(methylsulfanyl)-4-(propan-2-ylsulfonyl)-1H-pyrazol-3-amine | Formula: | C7 H13 N3 O2 S2 | SMILES: | c1(c(c(SC)nn1)S(=O)(=O)C(C)C)N | InChi: | InChI=1S/C7H13N3O2S2/c1-4(2)14(11,12)5-6(8)9-10-7(5)13-3/h4H,1-3H3,(H3,8,9,10) | Definition date: | 2015-09-23 | Last modified: | 2016-09-23 | Release date: | 2016-09-28 | Identifier: | 5-(methylsulfanyl)-4-(propan-2-ylsulfonyl)-1H-pyrazol-3-amine |
|
| 5GL | Name: | 4-propan-2-ylsulfanyl-1-propyl-6,7-dihydro-5~{H}-cyclopenta[d]pyrimidin-2-one | Formula: | C13 H20 N2 O S | SMILES: | CCCN1C(=O)N=C(SC(C)C)C2=C1CCC2 | InChi: | InChI=1S/C13H20N2OS/c1-4-8-15-11-7-5-6-10(11)12(14-13(15)16)17-9(2)3/h9H,4-8H2,1-3H3 | Definition date: | 2015-09-24 | Last modified: | 2016-09-23 | Release date: | 2016-09-28 | Identifier: | 4-propan-2-ylsulfanyl-1-propyl-6,7-dihydro-5~{H}-cyclopenta[d]pyrimidin-2-one |
|
| 5GY | Name: | 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-[(1R)-2-fluoro-1-hydroxyethyl]-5-(2-{[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}ethyl)-4-methyl-1,3-thiazol-3-ium | Formula: | C14 H22 F N4 O8 P2 S | SMILES: | Nc1c(cnc(C)n1)C[n+]2c(c(sc2C(O)CF)CCOP(=O)(O)OP(O)(=O)O)C | InChi: | InChI=1S/C14H21FN4O8P2S/c1-8-12(3-4-26-29(24,25)27-28(21,22)23)30-14(11(20)5-15)19(8)7-10-6-17-9(2)18-13(10)16/h6,11,20H,3-5,7H2,1-2H3,(H4-,16,17,18,21,22,23,24,25)/p+1/t11-/m1/s1 | Definition date: | 2015-09-24 | Last modified: | 2016-09-23 | Release date: | 2016-09-28 | Identifier: | 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-[(1R)-2-fluoro-1-hydroxyethyl]-5-(2-{[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}ethyl)-4-methyl-1,3-thiazol-3-ium |
|
| 5J4 | Name: | 2-[6-(cyclobuta-1,3-dien-1-ylamino)-1,3-benzothiazol-2-yl]-1,3-thiazol-4-ol | Formula: | C14 H9 N3 O S2 | SMILES: | c1(ccc3c(c1)sc(c2scc(n2)O)n3)NC4=CC=C4 | InChi: | InChI=1S/C14H9N3OS2/c18-12-7-19-13(17-12)14-16-10-5-4-9(6-11(10)20-14)15-8-2-1-3-8/h1-7,15,18H | Definition date: | 2015-09-29 | Last modified: | 2016-09-23 | Release date: | 2016-09-28 | Identifier: | 2-[6-(cyclobuta-1,3-dien-1-ylamino)-1,3-benzothiazol-2-yl]-1,3-thiazol-4-ol |
|
| 71P | Name: | ~{N}-[(7~{R})-1,2,3-trimethoxy-10-methylsulfanyl-9-oxidanylidene-6,7-dihydro-5~{H}-benzo[a]heptalen-7-yl]ethanamide | Formula: | C22 H25 N O5 S | SMILES: | COc1cc2CC[CH](NC(C)=O)C3=CC(=O)C(=CC=C3c2c(OC)c1OC)SC | InChi: | InChI=1S/C22H25NO5S/c1-12(24)23-16-8-6-13-10-18(26-2)21(27-3)22(28-4)20(13)14-7-9-19(29-5)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m1/s1 | Definition date: | 2016-08-12 | Last modified: | 2016-09-16 | Release date: | 2016-09-21 | Identifier: | ~{N}-[(7~{R})-1,2,3-trimethoxy-10-methylsulfanyl-9-oxidanylidene-6,7-dihydro-5~{H}-benzo[a]heptalen-7-yl]ethanamide |
|
| 67Q | Name: | 5-({[(3,4-difluorophenyl)sulfonyl]amino}methyl)-6-methyl-N-[(2-methyl-4H-1lambda~4~,3-thiazol-5-yl)methyl]pyrazine-2-carboxamide | Formula: | C18 H19 F2 N5 O3 S2 | SMILES: | c1(c(C)nc(cn1)C(=O)NCC=2CN=C(C)S=2)CNS(c3cc(c(cc3)F)F)(=O)=O | InChi: | InChI=1S/C18H19F2N5O3S2/c1-10-16(9-24-30(27,28)13-3-4-14(19)15(20)5-13)22-8-17(25-10)18(26)23-7-12-6-21-11(2)29-12/h3-5,8,24,29H,6-7,9H2,1-2H3,(H,23,26) | Definition date: | 2016-02-15 | Last modified: | 2016-09-16 | Release date: | 2016-09-21 | Identifier: | 5-({[(3,4-difluorophenyl)sulfonyl]amino}methyl)-6-methyl-N-[(2-methyl-4H-1lambda~4~,3-thiazol-5-yl)methyl]pyrazine-2-carboxamide |
|
| 6OZ | Name: | 2,4-dimethyl-5-[3-(2-phenylpropan-2-yl)-1H-pyrazol-5-yl]-1,3-thiazole | Formula: | C17 H19 N3 S | SMILES: | c1(ccccc1)C(c2nnc(c2)c3c(C)nc(C)s3)(C)C | InChi: | InChI=1S/C17H19N3S/c1-11-16(21-12(2)18-11)14-10-15(20-19-14)17(3,4)13-8-6-5-7-9-13/h5-10H,1-4H3,(H,19,20) | Definition date: | 2016-05-17 | Last modified: | 2016-09-02 | Release date: | 2016-09-07 | Identifier: | 2,4-dimethyl-5-[3-(2-phenylpropan-2-yl)-1H-pyrazol-5-yl]-1,3-thiazole |
|
| 6P1 | Name: | 5-{3-[(1R)-1-(4-methoxyphenyl)ethyl]-1H-pyrazol-5-yl}-2,4-dimethyl-1,3-thiazole | Formula: | C17 H19 N3 O S | SMILES: | c1(sc(c(C)n1)c3nnc(C(C)c2ccc(cc2)OC)c3)C | InChi: | InChI=1S/C17H19N3OS/c1-10(13-5-7-14(21-4)8-6-13)15-9-16(20-19-15)17-11(2)18-12(3)22-17/h5-10H,1-4H3,(H,19,20)/t10-/m1/s1 | Definition date: | 2016-05-17 | Last modified: | 2016-09-02 | Release date: | 2016-09-07 | Identifier: | 5-{3-[(1R)-1-(4-methoxyphenyl)ethyl]-1H-pyrazol-5-yl}-2,4-dimethyl-1,3-thiazole |
|
| 6P2 | Name: | 5-{3-[1-(4-methoxyphenyl)cyclopropyl]-1H-pyrazol-5-yl}-2,4-dimethyl-1,3-thiazole | Formula: | C18 H19 N3 O S | SMILES: | C2C(c1ccc(OC)cc1)(C2)c4cc(c3sc(nc3C)C)nn4 | InChi: | InChI=1S/C18H19N3OS/c1-11-17(23-12(2)19-11)15-10-16(21-20-15)18(8-9-18)13-4-6-14(22-3)7-5-13/h4-7,10H,8-9H2,1-3H3,(H,20,21) | Definition date: | 2016-05-17 | Last modified: | 2016-09-02 | Release date: | 2016-09-07 | Identifier: | 5-{3-[1-(4-methoxyphenyl)cyclopropyl]-1H-pyrazol-5-yl}-2,4-dimethyl-1,3-thiazole |
|
| 6PQ | Name: | 5-{3-[(4-methoxyphenyl)methyl]-1H-pyrazol-5-yl}-2,4-dimethyl-1,3-thiazole | Formula: | C16 H17 N3 O S | SMILES: | c3(c2cc(Cc1ccc(OC)cc1)nn2)sc(nc3C)C | InChi: | InChI=1S/C16H17N3OS/c1-10-16(21-11(2)17-10)15-9-13(18-19-15)8-12-4-6-14(20-3)7-5-12/h4-7,9H,8H2,1-3H3,(H,18,19) | Definition date: | 2016-05-18 | Last modified: | 2016-09-02 | Release date: | 2016-09-07 | Identifier: | 5-{3-[(4-methoxyphenyl)methyl]-1H-pyrazol-5-yl}-2,4-dimethyl-1,3-thiazole |
|
| 6PS | Name: | 2,4-dimethyl-5-{3-[(1R)-1-phenylethyl]-1H-pyrazol-5-yl}-1,3-thiazole | Formula: | C16 H17 N3 S | SMILES: | Cc1sc(c(n1)C)c2nnc(c2)C(c3ccccc3)C | InChi: | InChI=1S/C16H17N3S/c1-10(13-7-5-4-6-8-13)14-9-15(19-18-14)16-11(2)17-12(3)20-16/h4-10H,1-3H3,(H,18,19)/t10-/m1/s1 | Definition date: | 2016-05-18 | Last modified: | 2016-09-02 | Release date: | 2016-09-07 | Identifier: | 2,4-dimethyl-5-{3-[(1R)-1-phenylethyl]-1H-pyrazol-5-yl}-1,3-thiazole |
|
| 6WD | Name: | (4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-4-methyl-6-pyrimidin-5-yl-5,6-dihydro-1,3-thiazin-2-amine | Formula: | C15 H14 F2 N4 S | SMILES: | C[C]1(C[CH](SC(=N1)N)c2cncnc2)c3ccc(F)cc3F | InChi: | InChI=1S/C15H14F2N4S/c1-15(11-3-2-10(16)4-12(11)17)5-13(22-14(18)21-15)9-6-19-8-20-7-9/h2-4,6-8,13H,5H2,1H3,(H2,18,21)/t13-,15-/m0/s1 | Definition date: | 2016-07-08 | Last modified: | 2016-09-02 | Release date: | 2016-09-07 | Identifier: | (4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-4-methyl-6-pyrimidin-5-yl-5,6-dihydro-1,3-thiazin-2-amine |
|
| 731 | Name: | [5-(2,4-dimethyl-1,3-thiazol-5-yl)-1~{H}-pyrazol-3-yl]-(4-phenylpiperazin-1-yl)methanone | Formula: | C19 H21 N5 O S | SMILES: | Cc1sc(c(C)n1)c2[nH]nc(c2)C(=O)N3CCN(CC3)c4ccccc4 | InChi: | InChI=1S/C19H21N5OS/c1-13-18(26-14(2)20-13)16-12-17(22-21-16)19(25)24-10-8-23(9-11-24)15-6-4-3-5-7-15/h3-7,12H,8-11H2,1-2H3,(H,21,22) | Definition date: | 2016-08-18 | Last modified: | 2016-08-24 | Release date: | 2016-08-31 | Identifier: | [5-(2,4-dimethyl-1,3-thiazol-5-yl)-1~{H}-pyrazol-3-yl]-(4-phenylpiperazin-1-yl)methanone |
|
| 6G9 | Name: | 2-[[2-[[4,5-bis(bromanyl)-1~{H}-pyrrol-2-yl]carbonylamino]-1,3-benzothiazol-6-yl]amino]-2-oxidanylidene-ethanoic acid | Formula: | C14 H8 Br2 N4 O4 S | SMILES: | OC(=O)C(=O)Nc1ccc2nc(NC(=O)c3[nH]c(Br)c(Br)c3)sc2c1 | InChi: | InChI=1S/C14H8Br2N4O4S/c15-6-4-8(18-10(6)16)11(21)20-14-19-7-2-1-5(3-9(7)25-14)17-12(22)13(23)24/h1-4,18H,(H,17,22)(H,23,24)(H,19,20,21) | Definition date: | 2016-05-23 | Last modified: | 2016-08-24 | Release date: | 2016-08-31 | Identifier: | 2-[[2-[[4,5-bis(bromanyl)-1~{H}-pyrrol-2-yl]carbonylamino]-1,3-benzothiazol-6-yl]amino]-2-oxidanylidene-ethanoic acid |
|
| 6DA | Name: | N-[2-(morpholin-4-yl)ethyl]-6-(8-phenyl-1H-imidazo[4,5-c][1,7]naphthyridin-1-yl)-1,3-benzothiazol-2-amine | Formula: | C28 H25 N7 O S | SMILES: | C(CNc6nc5c(cc(n4cnc3cnc2c(cc(c1ccccc1)nc2)c34)cc5)s6)N7CCOCC7 | InChi: | InChI=1S/C28H25N7OS/c1-2-4-19(5-3-1)23-15-21-24(16-30-23)31-17-25-27(21)35(18-32-25)20-6-7-22-26(14-20)37-28(33-22)29-8-9-34-10-12-36-13-11-34/h1-7,14-18H,8-13H2,(H,29,33) | Definition date: | 2016-03-17 | Last modified: | 2016-08-18 | Release date: | 2016-08-23 | Identifier: | N-[2-(morpholin-4-yl)ethyl]-6-(8-phenyl-1H-imidazo[4,5-c][1,7]naphthyridin-1-yl)-1,3-benzothiazol-2-amine |
|